Concepedia

Hannah Edmondson‐Melançon

HE

Statistics

Publications

4

Citations

248

H-Index

4

Active since

2001

Affiliations

University of Southern California(Current)

Indiana University School of Medicine

Indiana University – Purdue University Indianapolis

Research Triangle Park Foundation

Hannah Edmondson‐Melançon is an author at University of Southern California specializing in pharmacotherapy, antiviral therapy, and antiretroviral therapy.

Publications per year

2001–2004

4

Publications

4

Prospective, Intensive Study of Metabolic Changes Associated with 48 Weeks of Amprenavir‐Based Antiretroviral Therapy

Michael P. Dubé, Dajun Qian, Hannah Edmondson‐Melançon et al. · Clinical Infectious Diseases · 2002 · 111 citations · Full text

, , +17

Prospective Evaluation of the Effect of Initiating Indinavir-Based Therapy on Insulin Sensitivity and B-Cell Function in HIV-Infected Patients

Michael P. Dubé, Hannah Edmondson‐Melançon, Dajun Qian et al. · JAIDS Journal of Acquired Immune Deficiency Syndromes · 2001 · 94 citations

, , +17

Prospective Evaluation of the Effect of Initiating Indinavir-Based Therapy on Insulin Sensitivity and B-Cell Function in HIV-Infected Patients

Michael P. Dubé, Hannah Edmondson‐Melançon, Dajun Qian et al. · JAIDS Journal of Acquired Immune Deficiency Syndromes · 2001 · 31 citations

, , +17

Changes in Thrombolytic and Inflammatory Markers After Initiation of Indinavir- or Amprenavir-Based Antiretroviral Therapy

Erika M. Young, Robert V. Considine, Fred R. Sattler et al. · Cardiovascular Toxicology · 2004 · 12 citations

, , +11

1–4 of 4